GGrantIndex
Sort

48,018 grants matching immunotherapy

EpCAM (CD326) Function in Epithelial Cell Biology and Immunophysiology

$837,016
Mark Udey · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Synthetic Nanoparticle-antibody (SNAb) Based Depletion of Myeloid-Derived Suppressor Cells for TB Host-Directed Therapy

$836,957
Jyothi Rengarajan · Emory University · R01 · FY2021 · AI

High Throughput Isolation of Antigen Specific T-cells for Cancer Therapy

$836,757
Udai S Kammula · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

Inflammation and cancer treatment

$836,682
David Wink · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Cytokines in AIDS and Cancer

$836,568
George N. Pavlakis · Division Of Basic Sciences - Nci · ZIA · FY2010 · CA

Molecular Allergy

$836,486
Robert E London · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

Product for sensitive imaging of cells in vivo

$836,418
Brooke Helfer · Celsense, Inc. · R44 · FY2019 · EB

Development of a potent and selective oral ENPP1 inhibitor for oncology

$836,231
Mohan Rao Kaadige · Stingray Therapeutics, Inc. · R44 · FY2023 · CA

FMIP COBRE Administrative Core

$836,222
Richard J Lamont · University Of Louisville · P20 · FY2024 · GM

Peptidoglycan Fragment Library to Investigate Innate Immune Responses

$836,110
Catherine Leimkuhler Grimes · University Of Delaware · R01 · FY2025 · AI

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease

$836,063
Walter J Atwood · Brown University · R35 · FY2022 · NS

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease

$836,063
Walter J Atwood · Brown University · R35 · FY2021 · NS

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease

$836,063
Walter J Atwood · Brown University · R35 · FY2025 · NS

Progressive Multifocal Leukoenephalopathy: Endemic Viruses and Lethal Brain Disease

$836,063
Walter J Atwood · Brown University · R35 · FY2023 · NS

Cancer Vaccines and Modulation of Checkpoint Controls in Immunization

$835,947
John Janik · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA

Biostatistics Shared Resources Core

$835,833
Deo Kumar S. Srivastava · St. Jude Children'S Research Hospital · P30 · FY2019 · CA

Cancer Therapy Clinical Trials Using Novel Recombinant Vaccines

$835,822
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Clinical trials employing cancer vaccine combination therapies

$835,822
James L. Gulley · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

B Cell Related Prophylaxis and Therapeutics

$835,818
Arturo Casadevall · Wadsworth Center · U54 · FY2008 · AI

Identification of human tumor-associated antigens

$835,772
Kwong Yok Tsang · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA

Overcoming pre-existing immunity to AAV to enhance AAV-based HIV immunotherapies

$835,249
Mauricio De Aguiar Martins · University Of Florida · R01 · FY2025 · AI

Biostatistics Shared Resources Core

$835,176
Motomi Mori · St. Jude Children'S Research Hospital · P30 · FY2021 · CA

Convergent allergen-specific antibodies in food allergy

$834,998
Sarita U Patil · Massachusetts General Hospital · R01 · FY2024 · AI

IL-2 Family Cytokines and their Receptors-- Biology of the IL-2 system

$834,964
Warren J Leonard · National Heart, Lung, And Blood Institute · ZIA · FY2011 · HL

Generation and Function of NK Cell Memory

$834,830
Ulrich H Von Andrian · Harvard Medical School · R01 · FY2017 · AI